Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Financing › Details

Hitachi–Showa Denko: investment, 201912–202004 acquisition of Hitachi Chemical for JPY964b ($8.8b)

	Period	2019-12-18 � 2020-04-28
	Money taker	Hitachi Chemical Co., Ltd. (TSE:4217)
	Today	Showa Denko Materials Co., Ltd.
	Group	Resonac (Group)
	Money source	Showa Denko K.K. (SDK)
	Group	Resonac (Group)
	Product	CHEMICALS
	Product 2	LIFE SCIENCES

Record changed: 2024-01-09

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Resonac (Group)

[1] Lift BioSciences Ltd.. (2/16/23). "Press Release: LIfT BioSciences and Minaris Regenerative Medicine Enter into a Manufacturing Partnership". London & Munich....
[2] Minaris Regnerative Medicine GmbH. (2/22/21). "Press Release: MaxiVAX and Minaris Regenerative Medicine Enter into a Manufacturing Partnership for MVX-ONCO-2 Cancer Immunotherapy". Geneva & Munich....
[3] Minaris Regnerative Medicine GmbH. (1/25/21). "Press Release: Dusan Kosijer Apppointed CEO of Minaris Regenerative Medicine GmbH". Munich....
[4] Minaris Regnerative Medicine GmbH. (9/23/20). "Press Release: Hitachi Chemical’s Global Regenerative Medicine Business Renamed Minaris Regenerative Medicine". Allendale, NJ, Munich & Yokohama....
[5] Apceth Biopharma GmbH. (5/11/20). "Press Release: Hitachi Chemical Advanced Therapeutics Solutions and apceth Biopharma GmbH Enter into Strategic Clinical and Commercial Manufacturing Agreements with bluebird bio". Allendale, NJ & Munich....
[6] Bluebird Bio, Inc.. (10/22/19). "Press Release: European Medicines Agency Approves Refined Commercial Manufacturing Specifications for Zynteglo". Cambridge, MA....
[7] Hitachi Chemical Co., Ltd.. (1/31/19). "Press Release: Notice Regarding the Stock Acquisition of Apceth Biopharma GmbH, a Contract Manufacturer of Regenerative Medicine Products"....
[8] Apceth Biopharma GmbH. (1/31/19). "Press Release: Hitachi Chemical Co. Ltd. to Acquire Apceth Biopharma GmbH". Munich....
[9] Apceth Biopharma GmbH. (11/16/18). "Press Release: Apceth Biopharma GmbH Manufactures DCprime’s Cell-based Cancer Vaccine for Phase II Clinical Study". Munich....
[10] Apceth Biopharma GmbH. (10/19/18). "Press Release: Apceth Biopharma Presents Positive Data Demonstrating Efficacy of Apceth-201 in Preclinical Models of Acute GvHD". Munich....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)